-
1
Effects of macitentan and selexipag across prognostic age groups in patients with pulmonary arterial hypertension
Published 2025-02-01Subjects: “…Pulmonary arterial hypertension…”
Get full text
Article -
2
Peak steps to measure ‘‘capacity for activity’’: Actigraphy in the ADAPT registry with oral treprostinil
Published 2025-05-01Subjects: “…pulmonary arterial hypertension…”
Get full text
Article -
3
Angiopoietin-2 and D-dimer add prognostic information to clinical risk in pulmonary arterial hypertension
Published 2025-02-01Subjects: “…pulmonary arterial hypertension…”
Get full text
Article -
4
Nymphaea pubescens Willd. extract and its flavonoid constituents vasodilate rat isolated pulmonary artery via NO-sGC-cGMP pathway
Published 2025-02-01Subjects: Get full text
Article -
5
Arduous management in treatment of elderly patient with pulmonary arterial hypertension and cardiopulmonary comorbidities
Published 2025-01-01Subjects: “…Elderly pulmonary arterial hypertension…”
Get full text
Article -
6
Mendelian randomization study of serum uric acid levels and urate-lowering drugs on pulmonary arterial hypertension outcomes
Published 2025-02-01Subjects: “…Pulmonary arterial hypertension…”
Get full text
Article -
7
Pulmonary hypertension in Finland 2008-2020: A descriptive real-world cohort study (FINPAH)
Published 2025-02-01Subjects: “…pulmonary arterial hypertension…”
Get full text
Article -
8
The role of the TAPSE/sPAP ratio as a predictor of mortality in Pulmonary Arterial Hypertension: Its value for patient risk stratification
Published 2025-02-01Subjects: Get full text
Article